Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

1.

p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?

de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, de Almeida Matsura M, Alvarenga M, Vassallo J.

Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):71-7.

PMID:
16540734
[PubMed - indexed for MEDLINE]
2.

Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.

Werling RW, Hwang H, Yaziji H, Gown AM.

Am J Surg Pathol. 2003 Jan;27(1):82-90.

PMID:
12502930
[PubMed - indexed for MEDLINE]
3.

Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.

de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, de Almeida Matsura M, Vassallo J, Alvarenga M.

Breast J. 2008 Jan-Feb;14(1):68-75. Epub 2007 Dec 11.

PMID:
18086274
[PubMed - indexed for MEDLINE]
4.

[P63 protein in the diagnosis of breast tubular carcinoma].

Noël JC, Fayt I, Fernandez-Aguilar S.

Ann Pathol. 2004 Sep;24(4):319-23. French.

PMID:
15567947
[PubMed - indexed for MEDLINE]
5.

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.

Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C.

Am J Surg Pathol. 2001 Aug;25(8):1054-60.

PMID:
11474290
[PubMed - indexed for MEDLINE]
6.

p63 expression in benign and malignant breast lesions.

Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ.

Histol Histopathol. 2004 Apr;19(2):465-71.

PMID:
15024707
[PubMed - indexed for MEDLINE]
7.

Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast.

Lele SM, Graves K, Gatalica Z.

Appl Immunohistochem Mol Morphol. 2000 Mar;8(1):32-6.

PMID:
10937046
[PubMed - indexed for MEDLINE]
8.

Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.

Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC.

Cancer. 2003 Jun 25;99(3):172-9.

PMID:
12811858
[PubMed - indexed for MEDLINE]
Free Article
9.

The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.

J Clin Pathol. 2007 Mar;60(3):315-20. Epub 2006 May 12.

PMID:
16698948
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.

Pavlakis K, Zoubouli C, Liakakos T, Messini I, Keramopoullos A, Athanassiadou S, Kafousi M, Stathopoulos EN.

Breast. 2006 Dec;15(6):705-12. Epub 2005 Dec 27.

PMID:
16384708
[PubMed - indexed for MEDLINE]
11.

Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast?

Ribeiro-Silva A, Zamzelli Ramalho LN, Garcia SB, Zucoloto S.

Pathol Oncol Res. 2003;9(1):20-3. Epub 2003 Apr 18.

PMID:
12704442
[PubMed - indexed for MEDLINE]
Free Article
12.

Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.

Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T.

Mod Pathol. 2002 Apr;15(4):397-405.

PMID:
11950913
[PubMed - indexed for MEDLINE]
Free Article
13.

The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.

Joshi MG, Lee AK, Pedersen CA, Schnitt S, Camus MG, Hughes KS.

Mod Pathol. 1996 Jan;9(1):57-62.

PMID:
8821958
[PubMed - indexed for MEDLINE]
14.

Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.

Hilson JB, Schnitt SJ, Collins LC.

Am J Surg Pathol. 2010 Jun;34(6):896-900. doi: 10.1097/PAS.0b013e3181dd60d3.

PMID:
20463570
[PubMed - indexed for MEDLINE]
15.

Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.

Rabban JT, Swain RS, Zaloudek CJ, Chase DR, Chen YY.

Mod Pathol. 2006 Oct;19(10):1351-7. Epub 2006 Jun 30.

PMID:
16810311
[PubMed - indexed for MEDLINE]
Free Article
16.

Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.

Edwards PC, Bhuiya T, Kelsch RD.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 May;97(5):613-9.

PMID:
15153875
[PubMed - indexed for MEDLINE]
17.

The usefulness of p63 as a marker of breast myoepithelial cells.

Batistatou A, Stefanou D, Arkoumani E, Agnantis NJ.

In Vivo. 2003 Nov-Dec;17(6):573-6. Review.

PMID:
14758723
[PubMed - indexed for MEDLINE]
18.

Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast.

Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV, Schmitt FC.

Appl Immunohistochem Mol Morphol. 2003 Mar;11(1):1-8.

PMID:
12610349
[PubMed - indexed for MEDLINE]
19.

Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63.

Douglas-Jones A, Shah V, Morgan J, Dallimore N, Rashid M.

Histopathology. 2005 Aug;47(2):202-8.

PMID:
16045782
[PubMed - indexed for MEDLINE]
20.

Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.

Gottlieb C, Raju U, Greenwald KA.

Mod Pathol. 1990 Mar;3(2):135-40.

PMID:
1691493
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk